Seagen

Updated:6/2/21
Country/Territory:U.S.
Headquarters:Bothell, Wash.
Industry:Pharmaceuticals
CEO:Clay B. Siegall
Website:https://www.seagen.com

Ticker:SGEN
Company type:Public
Revenues ($M):$2,176
Profits ($M):$614
Market value ($M):$25,176
Number of employees:2,092

Changed name from Seattle Genetics, Oct. 9, 2020. Market value as of March 31, 2021.

$ millions% change
Revenues ($M):$2,175.5137.3%
Profits ($M):$613.7-
Assets ($M):$4,000.9-
Total Stockholder Equity ($M):$3,488.1-

Profit as % of Revenues:28.2%
Profits as % of Assets:15.3%
Profits as % of Stockholder Equity:17.6%

Earnings Per Share ($):3.37

Total Return to Investors (last year):53.3%
Total Return to Investors (5 year, annualized):31.3%
Total Return to Investors (10 year, annualized):27.9%

Seagen stock chart

Seagen in Fortune Rankings

View the Full List